Malignant Tumor Treatment Technologies, Inc.

Malignant Tumor Treatment Technologies Inc. is currently conducting a clinical trial targeting canine intranasal adenocarcinoma at universities and private veterinary hospitals in the United States for FDA submission. For more details, please refer to the following link: https://www.acibiosciences.com/mt003